By Country

France manufacturing-site findings

at manufacturing sites in this country 34 findings drawn from 5 published documents. The most recent cases are below; the full set is in search.

See all France findings

Which agency cited it

US FDA 33
EMA (Europe) 1

Companies with the most findings

Recent findings

US FDA Excel Vision 2026-05-15

There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch or any ofits components to meet any ofits specifications whether or not the batch has been already distiibuted.

See every finding in this document View official source
US FDA Excel Vision 2026-05-15

Approp1iate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records ai·e instituted only by authorized personnel.

See every finding in this document View official source

Other countries

These findings are a record of the moment each document was published. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out — do not read them as the current state; check the regulator's official announcements for the latest status. Counts are measured from public data as of 2026-09-04, and findings are extracted automatically from the regulator's published documents. “View official source” on each case links directly to that document.